Adherence to prophylactic treatment in patients with haemophilia in Germany

被引：0
|
作者：
Miesbach, Wolfgang [1 ]
Kanins, Werner [2 ]
机构：
[1] Univ Hosp Frankfurt, Frankfurt, Germany
[2] Deutsch Hamophiliegesell, Hamburg, Germany
来源：
HAEMOPHILIA | 2016年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：6 / 6
页数：1
相关论文
共 50 条
  • [41] Adherence to prophylaxis in adult patients with severe haemophilia A
    Bonanad, S.
    Garcia-Dasi, M.
    Aznar, J. A.
    Mingot Castellano, E.
    Jimenez Yuste, V.
    Calle, M.
    Palma, A.
    Fernandez Lopez, M.
    Marco, P.
    Paloma, M.
    Perez Garrido, R.
    Fernandez Mosteirin, N.
    Galmes, B.
    Sanabria, M.
    Alvarez, M.
    HAEMOPHILIA, 2019, 25 : 166 - 167
  • [42] Unravelling adherence to prophylaxis in haemophilia: a patients' perspective
    Schrijvers, L. H.
    Kars, M. C.
    Beijlevelt-van der Zande, M.
    Peters, M.
    Schuurmans, M. J.
    Fischer, K.
    HAEMOPHILIA, 2015, 21 (05) : 612 - 621
  • [43] Unravelling Adherence to Prophylaxis in Haemophilia: A Patients' Perspective
    Schrijvers, M.
    Kars, M.
    Beijlevelt-Vander Zande, M.
    Peters, M.
    Schuurmans, M.
    Fischer, K.
    HAEMOPHILIA, 2015, 21 : 15 - 15
  • [44] Knowledge of disease and adherence in adult patients with haemophilia
    Lindvall, K.
    Colstrup, L.
    Loogna, K.
    Wollter, I. M.
    Gronhaug, S.
    HAEMOPHILIA, 2010, 16 (04) : 592 - 596
  • [45] Treatment patterns and cost-of-illness of severe haemophilia in patients with inhibitors in Germany
    Auerswald, G
    Prondzinski, MV
    Ehlken, B
    Kreuz, W
    Kurnik, K
    Lenk, H
    Scharrer, I
    Schramm, W
    Zimmermann, R
    HAEMOPHILIA, 2004, 10 (05) : 499 - 508
  • [46] Adherence to prophylaxis in adult patients with severe haemophilia A
    Bonanad, Santiago
    Garcia-Dasi, Maria
    Aznar, Jose A.
    Eva Mingot-Castellano, Maria
    Jimenez-Yuste, Victor
    Victoria Calle, Ma
    Palma, Antonio
    Fernanda Lopez-Fernandez, Maria
    Marco, Pascual
    Jose Paloma, Maria
    Fernandez-Mosteirin, Nuria
    Galmes, Bernat
    Sanabria, Martin
    Pilar Alvarez, Ma
    HAEMOPHILIA, 2020, 26 (05) : 800 - 808
  • [47] Prophylactic recombinant factor VIIa in haemophilia patients with inhibitors
    Young, G
    McDaniel, M
    Nugent, DJ
    HAEMOPHILIA, 2005, 11 (03) : 203 - 207
  • [48] Legal requirements for optimal haemophilia treatment in Germany
    Brackmann, Hans-Hermann
    THROMBOSIS RESEARCH, 2014, 134 : S68 - S71
  • [49] Prophylactic therapy in haemophilia
    Ljung, Rolf
    BLOOD REVIEWS, 2009, 23 (06) : 267 - 274
  • [50] What factors should influence the dosage and interval of prophylactic treatment in patients with severe haemophilia A and B?
    Petrini, P
    HAEMOPHILIA, 2001, 7 (01) : 99 - 102
12345